19Jun
Healthcare & Life Sciences Private Equity Deal Tracker: H.I.G BioHealth Sells Vertiflex to Boston Scientific
H.I.G. BioHealth Partners, the life-science investment affiliate of H.I.G. Capital, has announced the sale of Vertiflex to Boston Scientific. The total equity value of the sale is approximately $465 million in cash, with additional payments...
By:
McGuireWoods LLP
Related
On September 24, 2019, the U.S. Department of Labor (DOL) issued its final rule to update the salary...
Read More >
We previously wrote about whether and how public-private partnerships (P3s) could be the answer to U...
Read More >
With the California legislative year now closed, we know which proposals became reality and offer in...
Read More >
The City of Columbus is open for business (remotely) to accept and review zoning, site plan, and per...
Read More >
Due to recent and significantly increased spread of COVID-19, additional COVID-19 protocol guidance ...
Read More >
On February 19, 2020, the Internal Revenue Service (IRS) issued two highly anticipated items of guid...
Read More >